Lestinora (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, the central regulator of the circadian clock. This activation signals darkness, helping to shift the internal rhythm and promote the transition from wakefulness to sleep without directly depressing the central nervous system.

The appropriate dose of Lestinora is determined by a qualified prescriber based on the individual’s age, condition severity, and response to therapy. Healthcare professionals will select the strength and dosing schedule that best fits the patient’s needs.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting Lestinora.

To order Lestinora, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike sedative‑hypnotics that act on GABA receptors, melatonin works by normalising the body’s circadian signalling. This mechanism generally results in fewer cognitive side effects and a lower risk of dependence, making it a preferred option for short‑term regulation of sleep timing.

Lestinora should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lestinora is taken orally, usually shortly before the intended bedtime. The tablet or capsule is swallowed whole with a glass of water. Patients should follow the timing and dosage instructions provided by their prescriber for optimal effect.

Serious risks, although rare, include allergic reactions such as rash, swelling, or difficulty breathing, and mood alterations like depression or agitation. If any of these symptoms occur, the patient should seek immediate medical attention.

Lestinora is not recommended for individuals with known hypersensitivity to melatonin, for children unless specifically prescribed by a pediatric specialist, and for patients taking certain medications that may interact significantly, such as anticoagulants or immunosuppressants, without medical supervision.